BioCentury
ARTICLE | Clinical News

Rapid One regulatory update

August 14, 2006 7:00 AM UTC

ABMC received 510(k) clearance to market Rapid once lateral flow immunoassay to detect buprenorphine to treat narcotics addiction. ...